ModeX Therapeutics (OPK) announced the appointment of Giovanni Abbadessa, M.D., Ph.D. as Chief Medical Officer, a newly created position. Dr. Abbadessa has over two decades of experience in drug development, including most recently as Vice President at Sanofi (SNY), where he provided executive leadership for advancing oncology assets.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPK:
- Opko Health Subsidiary Restructures with Strategic Sale and Debt Settlement
- Labcorp Completes Acquisition of Select Assets of BioReference Health’s Diagnostics Business from OPKO Health
- Largest borrow rate increases among liquid names
- Opko Health price target raised to $2.25 from $1.50 at Barrington
- Opko Health reports Q2 EPS (1c), consensus (9c)